CSTL - Company ID 0001447362
The table below shows CASTLE BIOSCIENCES INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$22.13M | -$6.04M | -$6.83M | -$25.44M | -$21.43M | -$3.63M |
| Capital expenditure | $12.46M | $4.74M | $9.15M | $3.34M | $402.00K | $750.00K |
| Investing cash flow | -$25.80M | -$22.43M | -$19.70M | $16.58M | -$402.00K | -$750.00K |
| Dividends paid | - | - | - |
CASTLE BIOSCIENCES INC reported operating cash flow of $64.35M for fiscal year 2025. That is down 0.8% from $64.87M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from -$12.29M (FY 2018) to $64.35M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$5.03M | -$1.55M | $10.64M | $728.00K | $1.22M | $1.51M |